The FDA has green-lighted a new drug from Gilead Sciences as treatment for three types of blood cancer namely chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma and small lymphocytic lymphoma.
Zydelig (idelalisib) gets FDA approval for 3 types of cancer: Another Gilead blockbuster drug?
Tech Times - 25 Jul 2014 11:46
The FDA has green-lighted a new drug from Gilead Sciences as treatment for three types of blood cancer namely chronic lymphocytic leukemia, follicular B-cell non-Hodgkin lymphoma and small lymphocytic lymphoma.
Share this Article
Recommended